How is AOB hemolysis treated?

Hemolytic disease of the newborn (HDN) due to ABO incompatibility typically presents with mild symptoms. Most infants recover gradually following phototherapy and experience no long-term sequelae. Provided the hemolysis is not caused by Rh incompatibility, standard treatment approaches are appropriate. Phototherapy effectively reduces serum bilirubin levels. In conjunction with administration of pediatric-specific medications and intravenous immunoglobulin (IVIG) supplementation, this therapy helps inhibit macrophage-mediated destruction of red blood cells, thereby improving the hemolytic condition.